BON (Bon Natural Life) 3-Year EBITDA Growth Rate: 0.00% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BON Bon Natural Life Ltd BON
44 GF Score
Price $1.14
GF Value $0.75
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Bon Natural Life 3-Year EBITDA Growth Rate?

Bon Natural Life BON +3.64% 44 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2025. GuruFocus rates BON with a GF Score™ of 44/100 and a GF Value™ of $0.75 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,408 Chemicals companies, Bon Natural Life ranks worse than 71022.66% on this metric.

Bon Natural Life's EBITDA per Share for the six months ended in Sep. 2025 was $-0.16.

During the past 12 months, Bon Natural Life's average EBITDA Per Share Growth Rate was -100.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bon Natural Life was 97.40% per year. The lowest was -52.80% per year. And the median was 22.20% per year.


Bon Natural Life  (NAS:BON) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Bon Natural Life 3-Year EBITDA Growth Rate Related Terms


BON vs SNES, YMAT, GLGI: 3-Year EBITDA Growth Rate Comparison

For the Specialty Chemicals subindustry, Bon Natural Life's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bon Natural Life 3-Year EBITDA Growth Rate vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bon Natural Life's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bon Natural Life's 3-Year EBITDA Growth Rate falls into.


BON
44GF Score
Bon Natural Life Ltd BON
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bon Natural Life 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Bon Natural Life (BON) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Bon Natural Life and its competitors. According to the industry distribution chart, Bon Natural Life ranks #999999 out of 1408 companies in the Chemicals industry.
Is Bon Natural Life's 3-Year EBITDA Growth Rate too high?
Bon Natural Life's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Bon Natural Life ranks #999999 out of 1408 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Bon Natural Life has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's 3-Year EBITDA Growth Rate compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #999999 out of 1408 companies for 3-Year EBITDA Growth Rate. This places Bon Natural Life in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,408 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Bon Natural Life and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bon Natural Life's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.75, compared to a current price of $1.14 — trading 52% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Bon Natural Life's overall GF Score™ is 44/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Bon Natural Life (BON), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bon Natural Life (BON) Overvalued in 2026?

Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued. The current stock price of $1.14 is trading 52% above its estimated GF Value™ of $0.75. GuruFocus considers Bon Natural Life to be Significantly Overvalued.

Key valuation signals for BON:

  • 3-Year EBITDA Growth Rate: 0.00%
  • GF Value™: $0.75 vs. price of $1.14 (52% above fair value)
  • GF Score™: 44/100 with 9 warning signs

No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bon Natural Life Business Description

Address No.69 Jinye Road, Room 601, Block C, Gazelle Valley, High-Tech Zone, Shaanxi, Xi’an, CHN, 710060
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
44GF Score

Get the complete analysis for BON

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.14
Price
$0.75
GF Value